Time to Follow the Evidence: Glycemic control and cardiovascular benefits of new diabetes medications. Draznin B, Hirsch IB. Am J Med 2021 Jan 9. pii: S0002-9343(21)00004.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Draznin B, Hirsch IB. Time to Follow the Evidence: Glycemic control and cardiovascular benefits of new diabetes medications. Am J Med 2021 Jan 9. pii: S0002-9343(21)00004.
PMID: 33434557